NO20080103L - Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse - Google Patents
Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disseInfo
- Publication number
- NO20080103L NO20080103L NO20080103A NO20080103A NO20080103L NO 20080103 L NO20080103 L NO 20080103L NO 20080103 A NO20080103 A NO 20080103A NO 20080103 A NO20080103 A NO 20080103A NO 20080103 L NO20080103 L NO 20080103L
- Authority
- NO
- Norway
- Prior art keywords
- milk
- caseins
- bioactive
- obtaining
- methods
- Prior art date
Links
- 230000000975 bioactive effect Effects 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000011632 Caseins Human genes 0.000 title abstract 2
- 108010076119 Caseins Proteins 0.000 title abstract 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 2
- 235000021240 caseins Nutrition 0.000 title abstract 2
- 229940021722 caseins Drugs 0.000 title abstract 2
- 230000002255 enzymatic effect Effects 0.000 title abstract 2
- 235000013336 milk Nutrition 0.000 title abstract 2
- 239000008267 milk Substances 0.000 title abstract 2
- 210000004080 milk Anatomy 0.000 title abstract 2
- 102000014171 Milk Proteins Human genes 0.000 abstract 2
- 108010011756 Milk Proteins Proteins 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- 235000021239 milk protein Nutrition 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200501373A ES2319475B1 (es) | 2005-06-08 | 2005-06-08 | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
| PCT/ES2006/070079 WO2006131586A1 (es) | 2005-06-08 | 2006-06-08 | Péptidos bioactivos identificados en hidrolizados enzimáticos de caseínas lácteas y procedimiento de obtención |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080103L true NO20080103L (no) | 2008-03-04 |
Family
ID=37498152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080103A NO20080103L (no) | 2005-06-08 | 2008-01-07 | Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8354502B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2495250A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008545774A (cg-RX-API-DMAC7.html) |
| KR (1) | KR101343904B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN103254278B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006256720A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0611729A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2611416C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2319475B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007015528A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20080103L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006131586A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10331202A1 (de) | 2003-07-10 | 2005-03-31 | S.K. Enterprise Gmbh | Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms |
| BRPI0707042A2 (pt) * | 2006-03-24 | 2011-04-12 | Unilever Nv | produto alimentìcio e uso |
| DE102006036285A1 (de) * | 2006-08-03 | 2008-02-07 | "S.U.K." Beteiligungs Gmbh | Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms |
| EP2253324A1 (en) * | 2009-04-30 | 2010-11-24 | Consejo Superior De Investigaciones Cientificas | Use of a casein-derived peptide and compositions thereof as antihypertensive |
| JP5715117B2 (ja) * | 2010-02-24 | 2015-05-07 | 森永乳業株式会社 | 摂食障害治療剤 |
| CN103232526B (zh) * | 2012-12-12 | 2015-06-24 | 上海交通大学 | 一种生物活性多肽lplp及其制备和应用 |
| US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
| US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
| US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
| US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
| US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
| CN103616454B (zh) * | 2013-12-06 | 2015-06-03 | 贝因美婴童食品股份有限公司 | 一种定量检测人β-酪蛋白含量的方法以及试剂盒 |
| CN104073539B (zh) * | 2014-06-17 | 2017-03-29 | 黑龙江省乳品工业技术开发中心 | 一种牛乳β‑酪蛋白多元活性肽的制备方法及其应用 |
| JP2017048124A (ja) * | 2015-08-31 | 2017-03-09 | 森永乳業株式会社 | アミノペプチダーゼａ阻害剤 |
| ES2941238T3 (es) | 2015-11-20 | 2023-05-19 | Consejo Superior Investigacion | Péptidos antihipertensivos del aceite de oliva |
| CN107337710A (zh) * | 2017-07-26 | 2017-11-10 | 盐城卫生职业技术学院 | 一种抗高血压活性肽The‑The‑Pro及应用和药物组合物 |
| CN107814838A (zh) * | 2017-12-07 | 2018-03-20 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽ypqrdmpiqaf及其制备方法和应用 |
| CN107880106B (zh) * | 2017-12-11 | 2020-06-16 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽vpitptlnre及其制备方法和应用 |
| KR102073824B1 (ko) * | 2018-04-11 | 2020-02-05 | 강원대학교산학협력단 | 간 보호용 건강기능식품 및 이의 제조 방법 |
| CN109776652B (zh) * | 2019-01-30 | 2020-08-18 | 浙江省医学科学院 | 鳕鱼皮寡肽及其分离纯化方法和在制备ɑ-葡萄糖苷酶抑制剂及抗Ⅱ型糖尿病药物中的应用 |
| CN110498833B (zh) * | 2019-08-30 | 2021-01-15 | 华南理工大学 | 一种具有ace抑制作用的三肽及其应用 |
| US12359212B2 (en) | 2019-11-22 | 2025-07-15 | Mozza Foods, Inc. | Recombinant micelle and method of in vivo assembly |
| US11326176B2 (en) | 2019-11-22 | 2022-05-10 | Mozza Foods, Inc. | Recombinant micelle and method of in vivo assembly |
| CN111777665B (zh) * | 2020-07-24 | 2022-07-05 | 北京林业大学 | 一种核桃粕抗氧化肽faw及其制备方法与应用 |
| CN115505025A (zh) * | 2022-11-10 | 2022-12-23 | 东北农业大学 | 一种基于老年人静态消化模型的乳清蛋白源抗氧化肽的筛选 |
| CN116444608B (zh) * | 2022-11-30 | 2024-06-25 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽dpsffake及其制备方法与应用 |
| CN116444619B (zh) * | 2022-11-30 | 2024-07-16 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽ypfpgpihnslp及其制备方法与应用 |
| CN116444609B (zh) * | 2022-11-30 | 2024-06-04 | 内蒙古伊利实业集团股份有限公司 | 乳源活性肽lppplpsrwpl及其制备方法与应用 |
| CN118005726A (zh) * | 2024-01-31 | 2024-05-10 | 上海交通大学 | 一种来源于驼奶的生物活性肽wpeylkt及其制备方法和应用 |
| CN119170106B (zh) * | 2024-11-20 | 2025-02-11 | 中国农业大学 | 一种马乳乳清蛋白源抗氧化肽筛选和制备方法及其应用 |
| CN119569825A (zh) * | 2024-11-22 | 2025-03-07 | 贵阳学院 | 乳源广谱抗菌肽及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4444753C2 (de) | 1994-12-15 | 1998-08-06 | Forssmann Wolf Georg | Antibiotisch wirksame Peptide aus der bovinen Milch, deren Gewinnung und Verwendung |
| US6060448A (en) * | 1995-10-31 | 2000-05-09 | Pepsyn Limited | Casein fragments having growth promoting activity |
| AUPP051497A0 (en) | 1997-11-24 | 1997-12-18 | University Of Melbourne, The | Antimicrobial peptides |
| WO2000015655A1 (en) * | 1998-09-15 | 2000-03-23 | Nizo Food Research | Process for producing peptides from biological fluids and peptides obtainable by said process |
| US6514941B1 (en) | 1999-12-10 | 2003-02-04 | Campina Melkunie B.V. | Method of preparing a casein hydrolysate enriched in anti-hypertensive peptides |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| MXPA02011018A (es) | 2000-05-08 | 2004-08-19 | Davisco Internat Foods Inc | Tratamiento enzimatico de proteinas de suero para la produccion de peptidos de antihipertension, los productos resultantes y el tratamiento de hipertension en mamiferos. |
| GB0016189D0 (en) * | 2000-06-30 | 2000-08-23 | Pepsyn Ltd | Cosmetic composition |
| US6465432B1 (en) * | 2000-08-28 | 2002-10-15 | Kraft Food Holdings, Inc. | Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides |
| MXPA04001890A (es) * | 2001-08-30 | 2004-06-18 | Chay 13 Medical Res Group N V | Peptidos derivados de caseina y sus usos en terapia. |
| US7309491B2 (en) * | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
| WO2004089986A1 (en) | 2003-04-14 | 2004-10-21 | Stichting Voor De Technische Wetenschappen | Antimicrobial peptide from transferrin family |
-
2005
- 2005-06-08 ES ES200501373A patent/ES2319475B1/es not_active Expired - Lifetime
-
2006
- 2006-06-08 CA CA2611416A patent/CA2611416C/en not_active Expired - Fee Related
- 2006-06-08 BR BRPI0611729-5A patent/BRPI0611729A2/pt not_active IP Right Cessation
- 2006-06-08 AU AU2006256720A patent/AU2006256720A1/en not_active Abandoned
- 2006-06-08 EP EP12158198.7A patent/EP2495250A3/en not_active Withdrawn
- 2006-06-08 WO PCT/ES2006/070079 patent/WO2006131586A1/es not_active Ceased
- 2006-06-08 JP JP2008515233A patent/JP2008545774A/ja not_active Abandoned
- 2006-06-08 EP EP06764378A patent/EP1905779A4/en not_active Withdrawn
- 2006-06-08 MX MX2007015528A patent/MX2007015528A/es not_active Application Discontinuation
- 2006-06-08 CN CN201310023562.3A patent/CN103254278B/zh not_active Expired - Fee Related
- 2006-06-08 US US11/921,797 patent/US8354502B2/en not_active Expired - Fee Related
- 2006-06-08 CN CN200680029333.0A patent/CN101305017B/zh not_active Expired - Fee Related
-
2008
- 2008-01-07 NO NO20080103A patent/NO20080103L/no not_active Application Discontinuation
- 2008-01-08 KR KR1020087000546A patent/KR101343904B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006131586B1 (es) | 2007-02-01 |
| ES2319475B1 (es) | 2010-02-16 |
| EP2495250A3 (en) | 2013-07-10 |
| EP1905779A4 (en) | 2010-09-01 |
| WO2006131586A1 (es) | 2006-12-14 |
| KR101343904B1 (ko) | 2013-12-23 |
| CA2611416C (en) | 2015-10-06 |
| ES2319475A1 (es) | 2009-05-07 |
| CN101305017A (zh) | 2008-11-12 |
| KR20080045108A (ko) | 2008-05-22 |
| EP1905779A1 (en) | 2008-04-02 |
| BRPI0611729A2 (pt) | 2010-10-05 |
| MX2007015528A (es) | 2008-02-25 |
| CN103254278B (zh) | 2015-07-22 |
| JP2008545774A (ja) | 2008-12-18 |
| EP2495250A2 (en) | 2012-09-05 |
| US20100048464A1 (en) | 2010-02-25 |
| US8354502B2 (en) | 2013-01-15 |
| AU2006256720A1 (en) | 2006-12-14 |
| CA2611416A1 (en) | 2006-12-14 |
| CN103254278A (zh) | 2013-08-21 |
| CN101305017B (zh) | 2014-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080103L (no) | Bioaktive peptider identifisert i encymatiske hydrolyzater av caseiner fra melk og fremgangsmater for fremskaffelse av disse | |
| O’Regan et al. | Milk proteins | |
| PH12013500348A1 (en) | Nutritional products having improved organoleptic properties | |
| NO20071650L (no) | Proteinsystemer og matvarer inkludert de samme | |
| WO2008131008A3 (en) | Protein hydrolysate compositions having improved sensory characteristics and physical properties | |
| Cinq-Mars et al. | Optimizing angiotensin I-converting enzyme inhibitory activity of Pacific hake (Merluccius productus) fillet hydrolysate using response surface methodology and ultrafiltration | |
| SA112340123B1 (ar) | عملية للحصول على نواتج انحلال مائي لبروتين الأرز | |
| NO20083940L (no) | Fremgangsmater for redusering av proteinaggregering | |
| BR112012026906A2 (pt) | método para obtenção de produtos nutritivos à base de leguminosas | |
| BR112016023304A2 (pt) | célula hospedeira recombinante engendrada para superexpressar proteínas auxiliares | |
| DK1996028T3 (da) | Faste enzymformuleringer og fremgangsmåde til deres fremstilling | |
| MX2012001923A (es) | Composicion con alto contenido proteico para la industria alimenticia. | |
| DK2086356T3 (da) | Fremgangsmåde til opnåelse af knoldfrugtprotein-fraktioner med middelmolekylvægt, knoldfrugtprotein-fraktion og anvendelse af den samme | |
| PH12022552035A1 (en) | Structured high-protein meat analogue compositions | |
| PH12019502185A1 (en) | Hydrolysed vegetable proteins suitable for use in baby food | |
| WO2008060634A3 (en) | Human complement c3 derivatives with cobra venom factor-like function | |
| WO2010002160A3 (ko) | 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도 | |
| WO2007046891A3 (en) | Systems and methods for separating proteins from connective tissue | |
| ATE493999T1 (de) | Nahrungsmittel enthaltend dipeptide mit blutdrucksenkenden eigenschaften. | |
| WO2008071755A3 (fr) | Peptides derives de la caseine ayant une activité anxiolytique | |
| WO2010058100A8 (fr) | Protéines mutantes de la protéine f de piv-5 et de piv-2 | |
| WO2008070552A3 (en) | Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy | |
| EA200800289A1 (ru) | Новые ферменты для ферментативного отбеливания пищевых продуктов | |
| WO2006133014A3 (en) | Acid-thickened food compositions and products | |
| WO2015009829A3 (en) | Enhancement of osteogenic potential of bone grafts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |